In addition to cutaneous/subcutaneous and CNS fungal disease, many CARD9-deficient patients are also susceptible to persistent and recurrent infections of the mucosal surfaces by Candida species, collectively termed chronic mucocutaneous candidiasis (CMC). This evidence concerns the gene CARD9 and chronic mucocutaneous candidiasis.